Florida-based electronic data capture (EDC) provider OmniComm Systems inked 10 new contracts during the third quarter of 2007. The additional deals bring the company’s total contracts to 35 for the year.

Among the largest projects were a two-year phase III dermatology study enrolling more than 2,000 subjects at 100 sites and a two-year, anti-infective study with 500 subjects participating at 50 sites. The company cited the integration of Oracle Clinical with its EDC solution, TrialMaster, as being a critical factor in this year’s success.

The company also stated its CRO Preferred Program has brought in 17 CROs partnerships since April.

“CROs are enjoying the benefits of fixed pricing, no hidden costs or fees, a dedicated hosted environment and complete training and sales and marketing support, all distinct advantages of being an OmniComm partner,” said Stephen Johnson, executive vice president of business development.

OmniComm reported $1,076,000 in net sales during the third quarter of 2007 compared with $702,752 during the same period last year. However, it reported a net operating loss of $853,103 during the quarter compared with $759,945 last year.